California State Teachers Retirement System lowered its stake in Revvity Inc. (NYSE:RVTY - Free Report) by 3.8% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 128,780 shares of the company's stock after selling 5,029 shares during the quarter. California State Teachers Retirement System owned 0.12% of Revvity worth $14,328,063 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also bought and sold shares of the company. EdgePoint Investment Group Inc. boosted its holdings in Revvity by 3.1% in the first quarter. EdgePoint Investment Group Inc. now owns 8,800,863 shares of the company's stock worth $771,044,000 after acquiring an additional 265,204 shares in the last quarter. Jupiter Topco LLC acquired a new stake in Revvity during the second quarter worth about $961,017,000. Janus Henderson Group PLC raised its position in shares of Revvity by 2.3% in the first quarter. Janus Henderson Group PLC now owns 8,348,127 shares of the company's stock valued at $731,386,000 after buying an additional 186,956 shares during the last quarter. BlackRock Inc. purchased a new position in shares of Revvity during the second quarter worth $852,070,000. Finally, Dimensional Fund Advisors LP lifted its position in shares of Revvity by 11.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,917,953 shares of the company's stock worth $255,623,000 after buying an additional 305,837 shares during the last quarter. 86.65% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
RVTY has been the topic of a number of recent research reports. UBS Group began coverage on shares of Revvity in a research report on Wednesday, September 9th. They set a "neutral" rating and a $140.00 price target on the stock. Wall Street Zen cut Revvity from a "buy" rating to a "hold" rating in a report on Sunday, August 16th. Evercore reissued an "outperform" rating on shares of Revvity in a report on Wednesday, August 5th. KeyCorp boosted their target price on Revvity from $125.00 to $165.00 and gave the company an "overweight" rating in a research report on Friday, September 4th. Finally, Zacks Research raised shares of Revvity from a "strong sell" rating to a "hold" rating in a report on Tuesday, August 4th. Four equities research analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $116.57.
View Our Latest Research Report on RVTY
Revvity Stock Up 8.3%
Shares of RVTY traded up $10.69 during midday trading on Tuesday, reaching $139.18. The stock had a trading volume of 1,414,332 shares, compared to its average volume of 1,412,934. The company has a market cap of $15.53 billion, a price-to-earnings ratio of 66.18, a PEG ratio of 2.26 and a beta of 1.09. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.80 and a quick ratio of 1.50. The company's fifty day simple moving average is $118.03 and its two-hundred day simple moving average is $103.47. Revvity Inc. has a 1-year low of $81.22 and a 1-year high of $139.54.
Revvity (NYSE:RVTY - Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.21 by $0.20. Revvity had a return on equity of 8.34% and a net margin of 8.16%.The business had revenue of $729.69 million during the quarter, compared to analysts' expectations of $702.96 million. During the same quarter in the previous year, the business earned $1.18 EPS. The company's revenue for the quarter was down 1.3% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Equities research analysts expect that Revvity Inc. will post 5.36 earnings per share for the current year.
Revvity Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be paid a $0.07 dividend. The ex-dividend date is Friday, October 23rd. This represents a $0.28 annualized dividend and a yield of 0.2%. Revvity's dividend payout ratio is currently 13.33%.
About Revvity
(
Free Report)
Revvity, Inc is a life sciences and diagnostics company that provides technologies, products and services used by researchers, healthcare professionals and laboratories. Its offerings support applications across genomics, proteomics, cellular analysis, drug discovery, disease research and laboratory testing.
The company develops and supplies scientific instruments, reagents, consumables, software and workflow solutions. Its portfolio includes platforms for genetic and molecular analysis, imaging, high-throughput screening, biomarker research and single-cell analysis, as well as laboratory solutions used in areas such as reproductive health and newborn screening.
Revvity was established in 2023 following the separation of PerkinElmer's Applied, Food and Enterprise Services businesses from its Precision Diagnostics operations.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Revvity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.
While Revvity currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.